Macrophages, dendritic cells and T lymphocytes in rat buccal mucosa and dental pulp following 5-fluorouracil treatment

European Journal of Oral Sciences

Volumn 107, Issue 3, 1999, Pages 194-201

  Bültzingslöwen, Inger V ^a   Jontell, Mats ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

5 fluorouracil; 5 FU; Dental pulp; Immunocompetent cells; Oral mucosa

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CD2 ANTIGEN; FLUOROURACIL; HLA ANTIGEN CLASS 2; MEMBRANE ANTIGEN;

ANIMAL; ARTICLE; BASEMENT MEMBRANE; CELL COUNT; CELL LINEAGE; CONNECTIVE TISSUE; DENDRITIC CELL; DRUG EFFECT; ENZYME IMMUNOASSAY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; LANGERHANS CELL; LEWIS RAT; MACROPHAGE; MOUTH MUCOSA; RAT; T LYMPHOCYTE; TOOTH PULP;

ANIMALS; ANTIGENS, CD2; ANTIGENS, SURFACE; ANTIMETABOLITES, ANTINEOPLASTIC; BASEMENT MEMBRANE; CELL COUNT; CELL LINEAGE; CONNECTIVE TISSUE; DENDRITIC CELLS; DENTAL PULP; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; FLUOROURACIL; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOENZYME TECHNIQUES; LANGERHANS CELLS; MACROPHAGES; MOUTH MUCOSA; RATS; RATS, INBRED LEW; T-LYMPHOCYTES;

EID: 0033144819     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1046/j.0909-8836.1999.eos1070306.x     Document Type: Article

References (23)

1. DODD MJ, FACIONE NC, DIBBLE SL, MACPHAIL L. Comparison of methods to determine the prevalence and nature of oral mucositis. Cancer Pract 1996; 4: 312-318.
2. LOPRINZI CL, GHOSH C, CAMORIANO J, SLOAN J, STEEN PD, MICHALAK JC, SCHAEFER PL, NOVOTNY PJ, GERSTNER JB, WHITE DF, HATFIELD AK, QUELLA SK. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol 1997; 15: 1235-1238.
3. BJARNASON GA, KERR IG, DOYLE N, MACDONALD M, SONE M. Phase I study of 5-fluorouracil and leucovorin by a 14-day circadian infusion in metastatic adenocarcinoma patients. Cancer Chemother Pharmacol 1993; 33: 221-228.
4. WHITTINGTON R, NEUBERG D, TESTER WJ, BENSON ABR, HALLER DG. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial. J Clin Oncol 1995; 13: 227-232.
5. CAUDRY M, BONNEL C, FLOQUET A, MARSAULT C, QUETIN P, PUJOL J, MATON O, DUJOLS JP, CAUDRY Y, SKAWINSKI P, CARENCO J, MOKHTARI F, CELERIER D, QUINTON A, DEMEAUX H, MAIRE JP. A randomized study of bolus fluorouracil plus folinic acid versus 21-day fluorouracil infusion alone or in association with cyclophosphamide and mitomycin C in advanced colorectal carcinoma. Am J Clin Oncol 1995; 18: 118-125.
6. GREM JL, MCATEE N, MURPHY RF, HAMILTON JM, BALIS F, STEINBERG S, ARBUCK SG, SETSER A, JORDAN E, CHEN A, KOHLER DR, KOTITE B, ALLEGRA CJ. Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma. J Clin Oncol 1994; 12: 560-568.
7. CASCINU S, FEDELI A, FEDELI SL, CATALANO G. Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. Eur J Cancer Oral Oncol 1994; 30B: 234-236.
8. SONIS ST, LINDQUIST L, VAN VA, STEWART AA, STAM K, QU GY, IWATA KK, HALEY JD. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3. Cancer Res 1994; 54: 1135-1138.
9. HARRISON SD JR, DENINE EP, PECKHAM JC. Qualitative and quantitative toxicity of single and sequential sublethal doses of 5-fluorouracil in BDF mice. Cancer Treat Rep 1978; 62: 533-545.
10. OHTA Y, SUEKI K, KITTA K, TAKEMOTO K, ISHITSUKA H, YAGI Y. Comparative studies on the immunosuppressive effect among 5′-deoxy-5- fluorouridine, ftorafur, and 5-fluorouracil. Gann 1980; 71: 190-196.
11. CONNOLLY KM, DIASIO RB, ARMSTRONG RD, KAPLAN AM. Decreased immunosuppression associated with antitumor activity of 5-deoxy-5-fluorouridine compared to 5-fluorouracil and 5-fluorouridine. Cancer Res 1983; 43: 2529-2535.
12. MERLUZZI VJ, LAST-BARNEY K, SUSSKIND BM, FAANES RB. Recovery of humoral and cellular immunity by soluble mediators after 5-fluorouracil-induced immunosuppression. Clin Exp Immunol 1982; 50: 318-326.
13. GILMORE GL, DEPASQUALE DK, FISCHER BC, SHADDUCK RK. Enhancement of monocytopoiesis by granulocyte colony-stimulating factor: evidence for secondary cytokine effects in vivo. Exp Hematol 1995; 23: 1319-1323.
14. IBRAHIM EM, AL-MULHIM FA. Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients. Med Oncol 1997; 14: 47-51.
15. CARLSSON G, LARSSON PA, FRÖSING R, HAFSTRÖM LO, SPEARS CP, PETERSON A, GUSTAVSSON B. 5-Fluorouracil sensitive adenocarcinoma - a new experimental model in the rat. Anticancer Res 1995; 15: 433-439.
16. LINDE A. A method for the biochemical study of enzymes in the rat odontoblast layer during dentinogenesis. Arch Oral Biol 1972; 17: 1209-1212.
17. OKIJI T, JONTELL M, BELICHENKO P, BERGENHOLTZ G, DAHLSTROM A. Perivascular dendritic cells of the human dental pulp. Acta Physiol Scand 1997; 159: 163-169.
18. HEUFLER C, KOCH F, SCHULER G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 1988; 167: 700-705.
19. Bos IR, BURKHARDT A. Interepithelial cells of the oral mucosa. Light and electron microscopic observations in germfree, specific pathogen-free and conventionalized mice. J Oral Pathol 1980; 9: 65-81.
20. STEINMAN RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-296.
21. VETVICKA V, BILEJ M, KINCADE PW. Resistance of macrophages to 5-fluorouracil treatment. Immunopharmacology 1990; 19: 131-138.
22. ATHLIN L, DOMELLÖF L. Effects of fluorouracil, doxorubicin and FAM combination on human peritoneal macrophages. Chemotherapy 1987; 33: 287-290.
23. SONIS ST, TRACEY C, SHKLAR G, JENSON J, FLORINE D. An animal model for mucositis induced by cancer chemotherapy. Oral Surg Oral Med Oral Pathol 1990; 69: 437-443.